Larvol Delta - Recommendations-to-Optimize-the-Use-of-Volumetric-MRI-in-Huntington39s-Disease-Clinical-Trials

Huntington’s disease therapeutic - Anima Biotech, Takeda

http://www.ncbi.nlm.nih.gov/pubmed/34744964

Nov 10, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next